Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care... Show more
Ventas, Inc. is an S&P 500 healthcare real estate investment trust (REIT) that owns and manages a diversified portfolio of senior housing communities, outpatient medical buildings, life science and research centers, and other healthcare properties across North America and the United Kingdom. The company's Senior Housing Operating Portfolio (SHOP) represents its largest and fastest-growing segment, accounting for 56% of annualized net operating income as of Q1 2026. Ventas generates revenue through long-term leases, property management fees, and direct operating income from its senior housing assets. The company is widely followed by income-oriented investors due to its quarterly dividend and by growth investors focused on the powerful demographic trend of an aging U.S. population — the 80-and-over cohort is projected to grow roughly 30% over the next five years.
Over the 30-day period ending in late July 2026, Ventas shares climbed from $89.05 to $100.53, representing a gain of approximately 12.9%. The rally was broad-based and accompanied by above-average trading volumes, notably on July 2 when volume exceeded 6.5 million shares. The stock broke decisively through its prior 52-week high near $94.60 during the rally and reached new multi-year highs above $100.
Zooming out to the quarterly view, VTR has advanced roughly 18.7% from its close of $84.70 in late April. The quarterly trend reflects a powerful recovery from the early-June trough near $79 and sustained momentum fueled by first-quarter earnings strength, upward guidance revisions, and a steady stream of analyst upgrades. The quarter's performance underscores a structural re-rating as the market prices in stronger-than-expected SHOP NOI growth and a robust acquisition pipeline.
Several catalysts converged to propel Ventas higher during this window. On June 27, the stock was added to both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, triggering passive fund rebalancing that expanded the institutional ownership base. In early July, Barclays initiated coverage with an Equalweight rating and a $99 price target, citing expectations for high-single-digit to low-double-digit FFO-per-share growth driven by SHOP acquisitions and the ongoing transition of 45 assets from Brookdale management. Days later, BMO Capital analyst Juan C. Sanabria reiterated a Buy rating with a $100 target, and the consensus analyst rating stood at "Moderate Buy" with an average target near $96.17.
Fundamentally, investors responded to Ventas's raised 2026 guidance — including SHOP same-store cash NOI growth now expected at 15–17% at the midpoint — and the company's aggressive investment activity. Year-to-date senior housing acquisitions reached approximately $1.7 billion through late April, with full-year investment guidance raised to $3 billion. The combination of near-record-low new senior housing construction (approximately 1,500 unit starts in Q1 2026) and accelerating demand from an aging population created a compelling supply-demand narrative that resonated strongly with the market. Additionally, Ventas declared a quarterly dividend of $0.52 per share payable July 16, reinforcing its income appeal amid a favorable rate environment for REITs.
The broader quarterly rally was anchored by Ventas's Q1 2026 earnings report in late April, which delivered normalized FFO of $0.94 per share — beating consensus estimates — alongside revenue of $1.66 billion that surpassed expectations by roughly $80 million. Same-store SHOP NOI surged more than 15% year-over-year, with average occupancy reaching 90.4% (up 310 basis points) and RevPOR increasing 5%. The earnings beat prompted management to raise full-year net income and FFO guidance, and multiple analysts — including those at Evercore ISI, Mizuho, Wells Fargo, and Deutsche Bank — lifted their price targets in response. The subsequent Russell index inclusions added a passive-flow tailwind, while the company's updated ATM sales agreement (increased to $3 billion) and the $540 million Revel luxury independent-living portfolio acquisition demonstrated both capital-markets access and strategic deal execution. Although the stock experienced a sharp pullback in late May and early June — falling from around $90 to the $79 level amid broader macro uncertainty and concerns about interest-rate sensitivity — the fundamental SHOP story reasserted itself, driving a strong recovery through June and July.
In a market environment where data-driven decision-making is increasingly critical, Tickeron's Trending AI Robots page offers traders a curated view of top-performing AI trading bots. Tickeron's platform features hundreds of AI-powered trading bots covering thousands of tickers across diverse strategies, timeframes, and performance profiles. Rather than sifting through an overwhelming number of options, the Trending AI Robots section highlights only the most relevant and highest-performing bots, making it easier for investors to identify automated trading strategies aligned with their objectives. Whether a trader focuses on short-term momentum, swing trading, or longer-term trend following, these bots vary in methodology and risk parameters. Exploring the curated selection can help investors discover AI-driven tools designed for today's dynamic markets.
Investors should monitor several key factors in the near term. Ventas is scheduled to report second-quarter 2026 earnings on July 29 after market close, with the Zacks Consensus Estimate pegging normalized FFO at $0.96 per share and revenue at approximately $1.67 billion. The SHOP segment's occupancy trends, RevPOR growth, and margin expansion will be closely scrutinized, as will any updates to full-year 2026 guidance. Macroeconomic developments — particularly the Federal Reserve's interest-rate trajectory — remain critical given Ventas's approximately $12.5 billion debt load and projected $640 million in 2026 interest expenses. Additionally, the pace and pricing of senior housing acquisitions, cap-rate compression in the transaction market, and operator-level execution across the Brookdale transition assets will shape sentiment. While demographic tailwinds provide a durable long-term backdrop, near-term risks include labor cost inflation, competitive pressures in local senior housing markets, and potential tenant concentration issues with major operators such as WELL-peer Ardent and Kindred. The interplay between these catalysts and headwinds will likely determine whether VTR can sustain its recent momentum through the second half of 2026.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for VTR crossed bullishly above the 50-day moving average on June 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VTR advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 328 cases where VTR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for VTR moved out of overbought territory on July 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where VTR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on July 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VTR as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for VTR turned negative on July 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
VTR broke above its upper Bollinger Band on July 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. VTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.274) is normal, around the industry mean (2.915). VTR's P/E Ratio (170.018) is considerably higher than the industry average of (62.072). VTR's Projected Growth (PEG Ratio) (1.717) is slightly lower than the industry average of (3.232). Dividend Yield (0.021) settles around the average of (0.054) among similar stocks. P/S Ratio (7.003) is also within normal values, averaging (6.669).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines